It is worth noting that in ACC, BRCA, KIRP, and LUAD, CENPN showed an increasing trend with the progression of tumor stage, which indicates that CENPN may be a marker leading to the poor prognosis of these cancers.
← all excerpts
Diagnostics and immunological function of CENPN in human tumors: from pan-cancer analysis to validation in breast cancer.
1
—
—